Cargando…

Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study

[Figure: see text]

Detalles Bibliográficos
Autores principales: Krishnakumar, Illathu Madhavamenon, Jaja-Chimedza, Asha, Joseph, Ashil, Balakrishnan, Abhilash, Maliakel, Balu, Swick, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574875/
https://www.ncbi.nlm.nih.gov/pubmed/36304817
http://dx.doi.org/10.1017/jns.2022.72
_version_ 1784811198501355520
author Krishnakumar, Illathu Madhavamenon
Jaja-Chimedza, Asha
Joseph, Ashil
Balakrishnan, Abhilash
Maliakel, Balu
Swick, Andrew
author_facet Krishnakumar, Illathu Madhavamenon
Jaja-Chimedza, Asha
Joseph, Ashil
Balakrishnan, Abhilash
Maliakel, Balu
Swick, Andrew
author_sort Krishnakumar, Illathu Madhavamenon
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-9574875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95748752022-10-26 Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study Krishnakumar, Illathu Madhavamenon Jaja-Chimedza, Asha Joseph, Ashil Balakrishnan, Abhilash Maliakel, Balu Swick, Andrew J Nutr Sci Research Article [Figure: see text] Cambridge University Press 2022-09-09 /pmc/articles/PMC9574875/ /pubmed/36304817 http://dx.doi.org/10.1017/jns.2022.72 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Research Article
Krishnakumar, Illathu Madhavamenon
Jaja-Chimedza, Asha
Joseph, Ashil
Balakrishnan, Abhilash
Maliakel, Balu
Swick, Andrew
Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title_full Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title_fullStr Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title_full_unstemmed Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title_short Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
title_sort enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574875/
https://www.ncbi.nlm.nih.gov/pubmed/36304817
http://dx.doi.org/10.1017/jns.2022.72
work_keys_str_mv AT krishnakumarillathumadhavamenon enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy
AT jajachimedzaasha enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy
AT josephashil enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy
AT balakrishnanabhilash enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy
AT maliakelbalu enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy
AT swickandrew enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy